[Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 2. Preoperative studies and follow-up].
Preoperative investigations in ovarian cancer have shown that early diagnostic or screening is impossible by means of the leucocyte adherence inhibition test (LAI-test = LAI). However, this test is important for follow-up studies. The LAI can be an additional parameter for individual decision. It in the clinical supervision of patients has been shown that metastasizing and local recurrent tumors can be detected by this test approximately 4-8 weeks before clinical evidence.
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007158:Immunologic Techniques; D007957:Leukocyte Adherence Inhibition Test; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery
Immundiagnostische Untersuchungen beim Ovarialkarzinom mit dem Leukozytenadhärenzinhibitionstest (LAI-Test). 2. Mitteilung: Präoperative Untersuchungen und Verlaufskontrollen.